Thomas Edward Schoenherr
Known title: CEO, DiagnosticsCIK: 0002113721
Associated companies
Transaction History
| TEM | ▼ Sell | Open Market | 10,281 | $874K | 9/25/2026 | View on chart |
| TEM | ▼ Sell | Open Market | 2,694 | $189K | 8/21/2026 | View on chart |
| TEM | ▼ Sell | Open Market | 100 | $6K | 8/19/2026 | View on chart |
| TEM | ▼ Sell | Open Market | 2,994 | $180K | 8/19/2026 | View on chart |
| TEM | ▼ Sell | Open Market | 494 | $30K | 8/19/2026 | View on chart |
| TEM | ▼ Sell | Open Market | 3,094 | $173K | 8/19/2026 | View on chart |
| TEM | ▼ Sell | Open Market | 900 | $54K | 8/19/2026 | View on chart |
| TEM | ▼ Sell | Open Market | 500 | $29K | 8/19/2026 | View on chart |
| TEM | ▼ Sell | Open Market | 9,232 | $458K | 8/18/2026 | View on chart |
| TEM | ▼ Sell | Open Market | 1,580 | $70K | 5/19/2026 | View on chart |
| TEM | ▲ Buy | Grant | 13,642 | $0 | 5/4/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Tempus AI Expands Collaborations, Canaccord Raises Target to $95
Tempus AI is expanding its strategic collaborations to support future growth. Canaccord Genuity recently raised its price target for the stock to $95. This development occurs as the company prepares to report its third-quarter financial results on November 2.
Tempus AI Expands Collaborations, Canaccord Raises Target to $95. Tempus AI is expanding its strategic collaborations to support future growth. Canaccord Genuity recently raised its price target for the stock to $95. This development occurs as the company prepares to report its third-quarter financial results on November 2.